Check out our special #PrideMonth episode of Hematopoiesis, a podcast produced by the ASH Trainee Council, in which Drs. Emily Liang, Michael Hochman, Shail Maingi, MD and I discuss the changing landscape of career for #LGBTQ+ trainees. #meded 🏳️‍🌈🏳️‍⚧️ podcasts.apple.com/us/podcast/cel…

Dr. Nicola Potere reported that 15.5% of patients with distal DVT had recurrence following anticoagulation discontinuation. Patients with unprovoked events or diabetes and those only receiving 6 weeks of anticoagulation, are at higher risk of recurrent events! #ISTH2024

Please check out our latest work published in Blood Advances Pavlina Chrysafi Rushad Patell Jeff Zwicker, MD

A cute brilliant haematologist and a future leader! And a celebrity too🌟

We had a thunderous ⛈️ welcome to our new fellows this weekend!

Delighted to welcome these 7 brilliant, compassionate, and ambitious humans and physicians to our ⁦BIDMC Hematology/Oncology Fellowship⁩ community! We look forward to the journey ahead with all of you. ⁦BIDMC Department of Medicine⁩ ⁦Rushad Patell⁩

Grow your research career with us in Dublin RCSI School of Pharmacy and Biomolecular Sciences fully funded PhD position available. Deadline for application August 9th ⏱️ RCSI PG Research RCSI

A fantastic fellowship family luncheon filled with great food and even better karaoke!

On Wednesdays we wear purple!

We know that patients with #cancer assoc #VTE need 6 months of #cvCoag therapy, minimum. Who needs longer vs shorter therapy? Kristen Sanfilippo shares her approach.

Dr. Kristen Sanfilippo reporting new data on the incidence of major bleeding 🩸 and its related 30-day mortality in patients with CAT 👇 We need in incorporate these risks when tailoring anticoagulation but no good RAMs can help clinicians :( Dalhousie University #hematology symposium

Let’s strengthen community based hematology-oncology care with goal concordant training during fellowship! Rushad Patell Daniel A Roberts, MD Deepa Rangachari, MD, FASCO UMN H.O.T. Division Masonic Cancer Center, University of Minnesota

BIDMC Cancer Center and BIDMC Hematology/Oncology Fellowship are elated and proud to celebrate our very own senior fellow Dr. Alm Soravis Osataphan, MD for this incredibly well deserved recognition— may your curiosity and innovation continue to soar and lead us to new heights! Rushad Patell #ASCO25

From ASCO PD breakfast, call from ASCO President Dr. Zon re: need for better education on clinical operations and business, supported by work from our own #HemeOncMedEd team re: goal-concordant fellowship training and community-based practice- ASCO Edge program

The best part about ASCO is gathering with brilliant, kind humans who share a passion and tireless devotion for advancing the well-being and lives of people living with cancer— our BIDMC Hematology/Oncology Fellowship are shining stars in that universe! Mentorship + partnership = sustenance.

Congratulations to our graduating class of fellows! Our community is extremely proud of you and look forward to all of your future endeavors! BIDMC Cancer Center

Sharing much love and gratitude with and for these incredibly smart, kind, curious, joyful BIDMC Hematology/Oncology Fellowship graduates! May your stars shine bright always and everywhere life takes you! Rushad Patell

Rigorous,goal-concordant career development is a mandate for modern training and sustenance of our work force to meet patients’ and society’s needs. Check out our latest work on training for community-based careers: ascopubs.org/doi/10.1200/OP… #HemOncMedEd ASCO Rushad Patell

🌿 Up to 40% of adults with cancer use cannabis for symptoms, yet most oncology fellows feel unprepared to advise them, a study by BIDMC Deepa Rangachari, MD, FASCO & team finds training doubles the odds they’ll recommend it with confidence. Read more: tinyurl.com/3k8jauce

Defining unmet educational needs and designing targeted evidence-based innovations and education = better trained physicians and better care for our patients! Rushad Patell BIDMC Hematology/Oncology Fellowship #HemeOncMedEd